Literature DB >> 17948127

Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity.

Wojciech Ornatowski1, Jens F Poschet, Elizabeth Perkett, Jennifer L Taylor-Cousar, Vojo Deretic.   

Abstract

Progressive pulmonary disease and infections with Pseudomonas aeruginosa remain an intractable problem in cystic fibrosis (CF). At the cellular level, CF is characterized by organellar hyperacidification, which results in altered protein and lipid glycosylation. Altered pH of the trans-Golgi network (TGN) may further disrupt the protein processing and packaging that occurs in this organelle. Here we measured activity of the major TGN endoprotease furin and demonstrated a marked upregulation in human CF cells. Increased furin activity was linked to elevated production in CF of the immunosuppressive and tissue remodeling cytokine TGF-beta and its downstream effects, including macrophage deactivation and augmented collagen secretion by epithelial cells. As furin is responsible for the proteolytic processing of a range of endogenous and exogenous substrates including growth factors and bacterial toxins, we determined that elevated furin-dependent activation of exotoxin A caused increased cell death in CF respiratory epithelial cells compared with genetically matched CF transmembrane conductance regulator-corrected cells. Thus elevated furin levels in CF respiratory epithelial cells contributes to bacterial toxin-induced cell death, fibrosis, and local immunosuppression. These data suggest that the use of furin inhibitors may represent a strategy for pharmacotherapy in CF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948127      PMCID: PMC2030457          DOI: 10.1172/JCI31499

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  60 in total

1.  Development of cystic fibrosis and noncystic fibrosis airway cell lines.

Authors:  Joseph Zabner; Phil Karp; Michael Seiler; Stacia L Phillips; Calista J Mitchell; Mimi Saavedra; Michael Welsh; Aloysius J Klingelhutz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01-10       Impact factor: 5.464

2.  Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.

Authors:  Felix Ratjen; Hanna Walter; Maria Haug; Christoph Meisner; Hartmut Grasemann; Gerd Döring
Journal:  Pediatr Pulmonol       Date:  2007-03

3.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.

Authors:  E A Perkett; R M Lyons; H L Moses; K L Brigham; B Meyrick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Overexpression of R domain eliminates cAMP-stimulated Cl- secretion in 9/HTEo- cells in culture.

Authors:  A Perez; K A Risma; E A Eckman; P B Davis
Journal:  Am J Physiol       Date:  1996-07

5.  TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis.

Authors:  P D Arkwright; S Laurie; M Super; V Pravica; M J Schwarz; A K Webb; I V Hutchinson
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

6.  Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR.

Authors:  M Egan; T Flotte; S Afione; R Solow; P L Zeitlin; B J Carter; W B Guggino
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

7.  Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells.

Authors:  Norman E Kreiselmeier; Nathan C Kraynack; Deborah A Corey; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-29       Impact factor: 5.464

8.  Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

Authors:  G B Pier; M Grout; T S Zaidi; J C Olsen; L G Johnson; J R Yankaskas; J B Goldberg
Journal:  Science       Date:  1996-01-05       Impact factor: 47.728

9.  Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40.

Authors:  D C Gruenert; C B Basbaum; M J Welsh; M Li; W E Finkbeiner; J A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Furin regulates both the activation of Pseudomonas exotoxin A and the Quantity of the toxin receptor expressed on target cells.

Authors:  M Gu; V M Gordon; D J Fitzgerald; S H Leppla
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.609

View more
  15 in total

1.  Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.

Authors:  Chikara Ueyama; Hideki Horibe; Yuichiro Yamase; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-06-29

2.  Bcl-2 suppresses sarcoplasmic/endoplasmic reticulum Ca2+-ATPase expression in cystic fibrosis airways: role in oxidant-mediated cell death.

Authors:  Shama Ahmad; Aftab Ahmad; Elena S Dremina; Victor S Sharov; Xiaoling Guo; Tara N Jones; Joan E Loader; Jason R Tatreau; Anne-Laure Perraud; Christian Schöneich; Scott H Randell; Carl W White
Journal:  Am J Respir Crit Care Med       Date:  2009-02-06       Impact factor: 21.405

Review 3.  Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases.

Authors:  Erol A Gaillard; Pradeep Kota; Martina Gentzsch; Nikolay V Dokholyan; M Jackson Stutts; Robert Tarran
Journal:  Pflugers Arch       Date:  2010-04-18       Impact factor: 3.657

4.  T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance.

Authors:  Marko Pesu; Wendy T Watford; Lai Wei; Lili Xu; Ivan Fuss; Warren Strober; John Andersson; Ethan M Shevach; Martha Quezado; Nicolas Bouladoux; Anton Roebroek; Yasmine Belkaid; John Creemers; John J O'Shea
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

5.  A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity.

Authors:  John E Weldon; Laiman Xiang; Jingli Zhang; Richard Beers; Dawn A Walker; Masanori Onda; Raffit Hassan; Ira Pastan
Journal:  Mol Cancer Ther       Date:  2012-11-06       Impact factor: 6.261

6.  Processing of Pseudomonas aeruginosa exotoxin A is dispensable for cell intoxication.

Authors:  Juliette Morlon-Guyot; Jocelyn Méré; Anne Bonhoure; Bruno Beaumelle
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.609

7.  The Pseudomonas aeruginosa autoinducer 3O-C12 homoserine lactone provokes hyperinflammatory responses from cystic fibrosis airway epithelial cells.

Authors:  Matthew L Mayer; Jared A Sheridan; Christoph J Blohmke; Stuart E Turvey; Robert E W Hancock
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

Review 8.  A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.

Authors:  John E Weldon; Ira Pastan
Journal:  FEBS J       Date:  2011-06-02       Impact factor: 5.622

9.  Genetics of the first seven proprotein convertase enzymes in health and disease.

Authors:  Hannu Turpeinen; Zsuzsanna Ortutay; Marko Pesu
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

10.  Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.

Authors:  Masateru Hiyoshi; Kazu Okuma; Seiji Tateyama; Kazuya Takizawa; Masumichi Saito; Madoka Kuramitsu; Kumiko Araki; Kazuhiro Morishita; Seiji Okada; Naoki Yamamoto; Arya Biragyn; Kazunari Yamaguchi; Isao Hamaguchi
Journal:  Retrovirology       Date:  2015-08-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.